rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1999-7-22
|
pubmed:abstractText |
To test the hypothesis that, in humans with ischemic heart disease, nifedipine is a primary dilator of the coronary circulation and in general exerts a net positive effect on the balance of myocardial oxygen supply and demand.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0954-6928
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
185-94
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10352896-Aged,
pubmed-meshheading:10352896-Blood Flow Velocity,
pubmed-meshheading:10352896-Coronary Circulation,
pubmed-meshheading:10352896-Female,
pubmed-meshheading:10352896-Humans,
pubmed-meshheading:10352896-Male,
pubmed-meshheading:10352896-Middle Aged,
pubmed-meshheading:10352896-Myocardial Ischemia,
pubmed-meshheading:10352896-Nifedipine,
pubmed-meshheading:10352896-Retrospective Studies,
pubmed-meshheading:10352896-Systole,
pubmed-meshheading:10352896-Tomography, Emission-Computed,
pubmed-meshheading:10352896-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:10352896-Vasodilator Agents,
pubmed-meshheading:10352896-Ventricular Function, Left
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease.
|
pubmed:affiliation |
Department of Medicine (Cardiac Unit), Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|